In contrast to SCLC-A, -N, and -P subtypes, these SMARCA4-deficient SCLC-Y tumors retained RB1 expression and expressed synaptophysin, but lacked both CD56 and INSM1, a profile that is characteristic of SMARCA4-UT. This evidence concerns the gene SMARCA4 and small cell lung carcinoma.